Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf Herman Fridman

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Nature Reviews. Cancer|May 17, 2019
Tertiary lymphoid structures in the era of cancer immunotherapyCatherine Sautès-Fridman, Florent Petitprez, Julien Calderaro, et al.
Current Opinion in Immunology|January 18, 2011
Immunosurveillance in human non-viral cancersWolf Herman Fridman, Bernard Mlecnik, Gabriela Bindea, et al.
Trends in Cancer|March 15, 2022
C1q+ macrophages: passengers or drivers of cancer progressionMargot Revel, Catherine Sautès-Fridman, Wolf-Herman Fridman, et al.
Current Opinion in Immunology|March 9, 2010
Natural immunity to cancer in humansGabriela Bindea, Bernhard Mlecnik, Wolf-Herman Fridman, et al.
Critical Reviews in Oncology/Hematology|January 24, 2007
FcgammaR: The key to optimize therapeutic antibodies?Sophie Sibéril, Charles-Antoine Dutertre, Wolf-Herman Fridman, et al.
The Journal of Clinical Investigation|August 5, 2015
From mice to humans: developments in cancer immunoeditingMichele W L Teng, Jerome Galon, Wolf-Herman Fridman, et al.
Oncoimmunology|February 6, 2014
Characteristics of tertiary lymphoid structures in primary cancersJérémy Goc, Wolf-Herman Fridman, Catherine Sautès-Fridman, et al.
Immunology Letters|April 15, 2004
Fc gamma receptorsJoël F G Cohen-Solal, Lydie Cassard, Wolf-Herman Fridman, et al.
Medecine Sciences : M/S|October 11, 2017
[The complement system: a double edge sword in tumor progression]Marie Daugan, Remi Noe, Wolf Herman Fridman, et al.
Medecine Sciences : M/S|April 24, 2010
[Human lung cancer: role of TLR7 and TLR8 in cell survival and chemoresistance]Julien Cherfils-Vicini, Diane Damotte, Wolf-Herman Fridman, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Nature Reviews. Cancer|May 17, 2019
Tertiary lymphoid structures in the era of cancer immunotherapyCatherine Sautès-Fridman, Florent Petitprez, Julien Calderaro, et al.
Current Opinion in Immunology|January 18, 2011
Immunosurveillance in human non-viral cancersWolf Herman Fridman, Bernard Mlecnik, Gabriela Bindea, et al.
Trends in Cancer|March 15, 2022
C1q+ macrophages: passengers or drivers of cancer progressionMargot Revel, Catherine Sautès-Fridman, Wolf-Herman Fridman, et al.
Current Opinion in Immunology|March 9, 2010
Natural immunity to cancer in humansGabriela Bindea, Bernhard Mlecnik, Wolf-Herman Fridman, et al.
Critical Reviews in Oncology/Hematology|January 24, 2007
FcgammaR: The key to optimize therapeutic antibodies?Sophie Sibéril, Charles-Antoine Dutertre, Wolf-Herman Fridman, et al.
The Journal of Clinical Investigation|August 5, 2015
From mice to humans: developments in cancer immunoeditingMichele W L Teng, Jerome Galon, Wolf-Herman Fridman, et al.
Oncoimmunology|February 6, 2014
Characteristics of tertiary lymphoid structures in primary cancersJérémy Goc, Wolf-Herman Fridman, Catherine Sautès-Fridman, et al.
Immunology Letters|April 15, 2004
Fc gamma receptorsJoël F G Cohen-Solal, Lydie Cassard, Wolf-Herman Fridman, et al.
Medecine Sciences : M/S|October 11, 2017
[The complement system: a double edge sword in tumor progression]Marie Daugan, Remi Noe, Wolf Herman Fridman, et al.
Medecine Sciences : M/S|April 24, 2010
[Human lung cancer: role of TLR7 and TLR8 in cell survival and chemoresistance]Julien Cherfils-Vicini, Diane Damotte, Wolf-Herman Fridman, et al.
Pageof 11